Search by Drug Name or NDC
NDC 72189-0335-05 KETOROLAC TROMETHAMINE 5 mg/mL Details
KETOROLAC TROMETHAMINE 5 mg/mL
KETOROLAC TROMETHAMINE is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct Rx. The primary component is KETOROLAC TROMETHAMINE.
MedlinePlus Drug Summary
Ophthalmic ketorolac is used to treat itchy eyes caused by allergies. It also is used to treat swelling and redness (inflammation) that can occur after cataract surgery. Ketorolac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the release of substances that cause allergy symptoms and inflammation.
Related Packages: 72189-0335-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ketorolac Ophthalmic
Product Information
NDC | 72189-0335 |
---|---|
Product ID | 72189-335_d9a589b4-bd33-0e45-e053-2a95a90ae67d |
Associated GPIs | 86805035102020 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | KETOROLAC TROMETHAMINE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | KETOROLAC TROMETHAMINE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | OPHTHALMIC |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/mL |
Substance Name | KETOROLAC TROMETHAMINE |
Labeler Name | Direct Rx |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA203410 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 72189-0335-05 (72189033505)
NDC Package Code | 72189-335-05 |
---|---|
Billing NDC | 72189033505 |
Package | 5 mL in 1 BOTTLE (72189-335-05) |
Marketing Start Date | 2022-03-07 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL d9a589b4-bd32-0e45-e053-2a95a90ae67d Details
SPL UNCLASSIFIED SECTION
Before you use Ketorolac Tromethamine Ophthalmic solution 0.5% for the first time:
1.Check to make sure that the tamper evident ring between the bottle and the cap is not broken ( See Figure A). If the tamper evident ring is broken or missing, contact your pharmacist.
[Img-fig-a]
2.Tear off the tamper evident ring ( See Figure B).
[Img-fig-b]
3.To open the bottle, remove the cap by turning it in the counterclockwise direction ( See Figure C).
[Img-fig-c]
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Rev.10/2021
SPL UNCLASSIFIED SECTION
17.1 Slow or Delayed Healing
Patients should be informed of the possibility that slow or delayed healing may occur while using nonsteroidal anti-inflammatory drugs (NSAIDs).
17.2 Avoiding Contamination of the Product
Patients should be instructed to avoid allowing the tip of the bottle to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Also, to avoid the potential for cross-contamination, the patient should be advised to use one bottle for each eye following bilateral ocular surgery. The use of the same bottle of topical eye drops for both eyes following bilateral ocular surgery is not recommended.
17.3 Contact Lens Wear
Patients should be advised that ketorolac tromethamine ophthalmic solution 0.5% should not be administered while wearing contact lenses.
17.4 Intercurrent Ocular Conditions
Patients should be advised that if they develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery, they should immediately seek their physician’s advice concerning the continued use of ketorolac tromethamine ophthalmic solution 0.5%.
17.5 Concomitant Topical Ocular Therapy
Patients should be advised that if more than one topical ophthalmic medication is being used, the medicines should be administered at least 5 minutes apart.
Manufactured by:
Micro Labs Limited
Bangalore-560099, INDIA.
Manufactured for:
Micro Labs USA Inc.
Somerset, NJ 08873
Rev.10/2021
SPL UNCLASSIFIED SECTION
Ketorolac Tromethamine Ophthalmic solution 0.5% is supplied sterile, in white opaque LDPE bottles with white opaque LDPE Nozzles with HDPE grey caps as follows.
3 mL in 5 mL bottle NDC 42571-137-31
5 mL in 5 mL bottle NDC 42571-137-25
10 mL in 10 mL bottle NDC 42571-137-26
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
SPL UNCLASSIFIED SECTION
Two controlled clinical studies showed that ketorolac tromethamine ophthalmic solution was significantly more effective than its vehicle in relieving ocular itching caused by seasonal allergic conjunctivitis.
Two controlled clinical studies showed that patients treated for two weeks with ketorolac tromethamine ophthalmic solution were less likely to have measurable signs of inflammation (cell and flare) than patients treated with its vehicle.
Results from clinical studies indicate that ketorolac tromethamine has no significant effect upon intraocular pressure; however, changes in intraocular pressure may occur following cataract surgery.
SPL UNCLASSIFIED SECTION
Ketorolac tromethamine ophthalmic solution 0.5% is a member of the pyrrolo-pyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use. Its chemical name is (±)-5-Benzoyl-2,3-dihydro-1H pyrrolizine-1-carboxylic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) and it has the following structure:
Ketorolac tromethamine ophthalmic solution 0.5% is supplied as a sterile isotonic aqueous 0.5% solution, with a pH of 7.4. Ketorolac tromethamine ophthalmic solution 0.5% is a racemic mixture of R-(+) and S-(-)- ketorolac tromethamine. Ketorolac tromethamine may exist in three crystal forms. All forms are equally soluble in water. The pKa of ketorolac is 3.5. This white to off-white crystalline substance discolors on prolonged exposure to light. The molecular weight of ketorolac tromethamine is 376.41. The osmolality of ketorolac tromethamine ophthalmic solution 0.5% is 290 mOsmol/kg.
Each mL of ketorolac tromethamine ophthalmic solution contains: Active: ketorolac tromethamine 0.5%. Preservative: benzalkonium chloride 0.01%. Inactives: edetate disodium 0.1%; octoxynol 40; water for injection; sodium chloride; hydrochloric acid and/or sodium hydroxide to adjust the pH.
SPL UNCLASSIFIED SECTION
Ketorolac tromethamine ophthalmic solution 0.5% is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. Ketorolac tromethamine ophthalmic solution 0.5% is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
INGREDIENTS AND APPEARANCE
KETOROLAC TROMETHAMINE
ketorolac tromethamine solution |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Direct Rx (079254320) |
Registrant - Direct Rx (079254320) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Direct Rx | 079254320 | relabel(72189-335) |